Log in to search using one of your social media accounts:

 

Firefighters May Face Higher Odds for Skin Cancer
Source: HealthDay Related MedlinePlus Pages: Melanoma, Occupational Health, Skin Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 13, 2017 Category: Consumer Health News Source Type: news

Researchers develop test that can diagnose two cancer types
(Georgia State University) A blood test using infrared spectroscopy can be used to diagnose two types of cancer, lymphoma and melanoma, according to a study led by Georgia State University. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 12, 2017 Category: Cancer & Oncology Source Type: news

Insights on how SHARPIN promotes cancer progression
(Sanford-Burnham Prebys Medical Discovery Institute) SBP and Technion Institute researchers have SHARPIN-ed their knowledge of how a malicious form of a protein drives the formation of melanoma through modulation of the PRMT5 pathway. The new research was published in the Journal of Clinical Investigation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2017 Category: Cancer & Oncology Source Type: news

Novel compound restores immune response in patients with melanoma
(European Society for Medical Oncology) A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2017 Category: Cancer & Oncology Source Type: news

Family members without inherited mutation have increased risk of melanoma
(Karolinska Institutet) In families who carry certain inherited mutations that increase the risk for melanoma, members who do not carry the mutation also have an increased risk of melanoma, a study from Karolinska Institutet published in Genetics in Medicine reports. The phenomenon, which is called phenocopy, could result from other shared risk-enhancing genes or environmental factors within the families. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2017 Category: Cancer & Oncology Source Type: news

University hospitals train hairdressers to spot melanoma
Researchers from the University of Colorado and the University of Southern California are training hairdressers to recognize melanomas in a move that could reduce deaths in under-served groups. (Source: the Mail online | Health)
Source: the Mail online | Health - December 7, 2017 Category: Consumer Health News Source Type: news

Chicago mother considers abortion after developing cancer
Lea Grover, 33, considered getting an abortion after having a pregnancy scare last year. The writer from Chicago developed malignant melanoma during each of her pregnancies. (Source: the Mail online | Health)
Source: the Mail online | Health - December 7, 2017 Category: Consumer Health News Source Type: news

Research Finds Popular Blood Pressure Drug Increases Skin Cancer Risk
This study shows a possible link between HCTZ and basal cell and squamous cell carcinomas of the skin. These are not melanomas, the deadliest form of skin cancer, but they both can pose serious health risks. This study shows an association between HCTZ and skin cancer, not proof that the medication actually causes cancer, but it’s link that needs to be studied further. In the meantime, continue to take your blood pressure medication and protect yourself from excessive sun exposure. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 6, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Dr. Mallika Marshall Source Type: news

PET/CT helps identify best prostate cancer regimen
Prostate-specific membrane antigen (PSMA) PET/CT scans can help identify prostate...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT could improve treatment for NSCLC patients FDG-PET/CT contributes to anal cancer follow-up AI algorithm can classify bone lesions on PET/CT images FDG-PET/CT foretells melanoma therapy response New PET tracer could work well for prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 6, 2017 Category: Radiology Source Type: news

Could Your Hair Dresser Save Your Life?
Researchers are exploring ways to improve early melanoma detection by training hair dressers to recognize potentially cancerous skin lesions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 6, 2017 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

Medical News Today: Common blood pressure drug raises skin cancer risk
New research shows that people who take the popular hypertension drug hydrochlorothiazide may put themselves at a dramatically high risk of skin cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 6, 2017 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

Genes associated with progression of melanoma are identified
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Screening used synthetic compound similar to curcumin (a pigment extracted from turmeric), which displayed anti-tumor action in preliminary tests. Next step will be evaluating these genes' roles on tumoral progression and exploring them as therapeutic targets - melanoma is the most lethal and also the most chemotherapy-resistant type of skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2017 Category: Cancer & Oncology Source Type: news

Role of melanoma-promoting protein revealed
New findings by Yale researchers suggest that targeting the gene MELK might be a promising therapeutic option for treating the deadly skin cancer. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 5, 2017 Category: Universities & Medical Training Source Type: news

Medical News Today: Could targeting this gene stop melanoma from spreading?
New research identifies a gene that helps melanoma to spread in both an animal model and human cells. Blocking its activity may stop metastasis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2017 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

Melanoma Research Alliance and Antidote Technologies Unveil Clinical...
Clinical Trial Locator allows patients to quickly and easily find clinical trial matches on the Melanoma Research Alliance website.(PRWeb December 05, 2017)Read the full story at http://www.prweb.com/releases/2017/12/prweb14978250.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 5, 2017 Category: Pharmaceuticals Source Type: news

Suicide risk in melanoma: what do we know? - Komic A, Taludker A, Walsh N, Jones A, Lawson A, Bateson B, Kruse EJ.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - December 4, 2017 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

UMMS scientists identify gene associated with metastatic melanoma
(University of Massachusetts Medical School) A study by Craig J. Ceol, Ph.D., assistant professor of molecular medicine at the University of Massachusetts Medical School, has revealed a protein active during early embryo development called GDF6 plays a primary role in metastatic melanoma. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 4, 2017 Category: Biology Source Type: news

Medical News Today: What is acral lentiginous melanoma?
We look at acral lentiginous melanoma, a type of skin cancer that affects the hands and feet. Learn about symptoms, diagnosis, and treatment options. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 2, 2017 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

How a New Genomic Test Could Change Cancer Care
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the U.S. Food and Drug Administration (FDA) approved FoundationOne CDx™, the company’s comprehensive companion diagnostic test for solid tumors. FoundationOne CDx is intended for use by health care professionals to help inform cancer treatment management in accordance with professional guidelines for patients with solid tumors. The first and only FDA-approved test of its kind for all solid tumors, FoundationOne CDx is a diagnostic test that acts as: “Access to important genomic information is ...
Source: MDDI - December 1, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Source Type: news

Epacadostat + Pembro for Melanoma: Beneficial, Well Tolerated Epacadostat + Pembro for Melanoma: Beneficial, Well Tolerated
This combination produced impressive response and disease control rates with good tolerability in treatment-naive patients with advanced melanoma.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 30, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Caught in the act: Papillomaviruses promote non-melanoma skin cancer
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) UV radiation has been known for a long time to be a risk factor for the development of skin cancer. Simultaneous infection with human papillomaviruses (HPV) has also been suspected to promote skin cancer, particularly in organ transplant recipients. Scientists from the German Cancer Research Center (DKFZ) have now been able to show for the first time in a natural system that papillomaviruses associated with UV light promote the development of non-melanoma skin cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 30, 2017 Category: International Medicine & Public Health Source Type: news

Viagra now available from a pharmacy without a prescription
Viagra Connect reclassified from POM to P by the MHRA Related items fromOnMedica Largest recorded seizure of fake medicines announced Health risk of unlicensed drugs in herbal supplements ED drugs unlikely to increase malignant melanoma risk Warning on buying unlicensed erectile dysfunction drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 29, 2017 Category: UK Health Source Type: news

This 'sweet spot' could improve Melanoma diagnosis
(Florida Atlantic University) Too much, too little, just right. It might seem like a line from 'Goldilocks and the Three Bears,' but actually describes an important finding that will enhance computer-aided diagnosis (CADx) of melanoma. Thanks to the algorithm the researchers created - which can be used in mobile apps that are being developed to diagnose suspicious moles -- they were able to determine the 'sweet spot' in classifying images of skin lesions. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2017 Category: Cancer & Oncology Source Type: news

Mount Sinai scientists identify novel therapeutic targets for metastatic melanoma
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers have identified novel therapeutic targets for metastatic melanoma, according to a study published in Molecular Cell. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 27, 2017 Category: Cancer & Oncology Source Type: news

PET/CT, MRI foretell developing neurofibromas
CHICAGO - Researchers from Spain are following the adage "forewarned is forearmed"...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT could improve treatment for NSCLC patients FDG-PET/CT contributes to anal cancer follow-up FDG-PET/CT foretells melanoma therapy response SNMMI: PET/CT with prostate agent changes therapy plans FDG-PET/CT can direct biopsies for pediatric cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 26, 2017 Category: Radiology Source Type: news

Mother diagnosed with skin cancer by SkinVision app  
Louise Burgess, 45, from Canberra, was diagnosed with stage one melanoma in May this year after she noticed a mole changed shape last November and used the SkinVision app to track its progress. (Source: the Mail online | Health)
Source: the Mail online | Health - November 24, 2017 Category: Consumer Health News Source Type: news

GST makes ‘orphan drugs’ prices soar
These high-value ‘orphan’ drugs used in bone marrow transplant, classical Hodgkin Lymphoma, Crohn’s disease and melanoma. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 24, 2017 Category: Pharmaceuticals Source Type: news

Schatton Awarded $2M National Cancer Institute Grant
Tobias Schatton, PhD, of the Department of Dermatology, received a research grant from the National Cancer Institute to study the role of the programmed cell death 1 (PD-1) pathway in melanoma. (Source: BWH News)
Source: BWH News - November 20, 2017 Category: Hospital Management Source Type: news

A Radioactive Cloud from Russia Swept Over Europe — and No One Knows Why
A mysterious radioactive cloud that swept through much of Europe this fall has officials baffled. The cloud was harmless and has dissipated, France’s Institute for Radiological Protection and Nuclear Safety wrote in a statement Thursday, but between Sept. 27 and Oct. 13, the radioactive nuclide Ruthenium 106 was detected in “the majority of European countries.” Experts aren’t totally sure where the substance came from, though testing suggests it was first released during the last week of September in Russia or Kazakhstan, likely somewhere between Russia’s Volga River and Ural Mountains. &ldquo...
Source: TIME.com: Top Science and Health Stories - November 10, 2017 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized europe France Nuclear onetime radiaoctive Science Source Type: news

Ludwig researchers uncover novel mechanism by which tumors evade cancer immunotherapies
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumors of the aggressive skin cancer melanoma can resist cancer immunotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news

Cancer immunotherapy uses melanin against melanoma
(North Carolina State University) Researchers have developed a melanin-enhanced cancer immunotherapy technique that can also serve as a vaccine, based on early experiments done in a mouse model. The technique is applied via a transdermal patch. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 10, 2017 Category: Biology Source Type: news

Advancing the treatment of melanoma
There is still a lot to learn about the genetic changes that occur as melanoma tumours form - and about the body's response to this illness. Greater understanding could help to predict how individual tumours are likely to respond to various combinations of therapies. An EU-funded network is training young researchers who are exploring this issue. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 10, 2017 Category: Research Source Type: news

OncoSec Medical names new CEO | Personnel Moves – Nov. 9, 2017
OncoSec Medical (NSDQ:ONCS)  announced earlier this week that the company’s co-founder, Punit Dhillon, would step down as CEO and continue to serve as president while Daniel O’Connor takes over the corner office. O’Connor joined OncoSec’s board of directors in September this year. “We are pleased to welcome Dan to OncoSec at this important time, and believe he is uniquely qualified to lead the company through the successful completion of its phase IIb registration directed trial, Pisces/Keynote-695 in patients with unresectable metastatic melanoma who have progressed or are progressi...
Source: Mass Device - November 9, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Wall Street Beat Aerie Pharmaceuticals Anika Therapeutics Inc. bostonbiomedical BrainStorm Cell Therapeutics Inc. DelMar Pharmaceuticals Express Scripts GlaxoSmithKline plc Onc Source Type: news

Low-cost device to diagnose skin cancer wins international Dyson award
Hand-held device dubbed sKan measures skin temperature to quickly and accurately identify melanoma, and could save lives around the worldA low-cost hand-held device which could help save lives across the world by diagnosingskin cancer early has won its inventors a prestigious international award and cash prize of £30,000.Four graduates ofMcMaster University in Canada have scooped theJames Dyson award for their invention, dubbed sKan: an easy-to-use gadget which measures skin temperature to quickly and accurately identify melanoma.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 9, 2017 Category: Science Authors: Rebecca Smithers Consumer affairs correspondent Tags: Science prizes Cancer research James Dyson Technology Skin cancer Health Medical research Society Source Type: news

UCLA helps many to live long and prosper
In Westwood, more than 100 faculty experts from 25 departments have embarked on anall-encompassing push to cut the health and economic impacts of depression in half by the year 2050. The mammoth undertaking will rely on platforms developed by the new Institute for Precision Health, which will harness the power of big data and genomics to move toward individually tailored treatments and health-promotion strategies.On the same 419 acres of land, researchers across the spectrum, from the laboratory bench to the patient bedside, are ushering in a potentially game-changing approach to turning the body ’s immune defenses a...
Source: UCLA Newsroom: Health Sciences - November 9, 2017 Category: Universities & Medical Training Source Type: news

Waiting Even a Month to Remove Melanoma Can Be Deadly
Title: Waiting Even a Month to Remove Melanoma Can Be DeadlyCategory: Health NewsCreated: 11/7/2017 12:00:00 AMLast Editorial Review: 11/8/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 8, 2017 Category: Cancer & Oncology Source Type: news

Bringing natural killer cells to the tumor battlefield
(Luxembourg Institute of Health) By studying melanoma, a highly malignant form of skin cancer, Dr Bassam Janji's research team at the Luxembourg Institute of Health (LIH) has revealed a mechanism by which the immunosuppressive environment can be switched to an immunosupportive one. They found that if autophagy -- the intracellular recycling process -- is blocked in tumor cells, they produce cytokines that attract NK cells. The massive recruitment of NK cells allows killing cancer cells and lets the tumors shrink. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Advancing women's health through scientific mobility
A Marie Skłodowska-Curie fellowship grant has enabled an ambitious young French researcher to make important advances in identifying a possible genetic association between endometriosis (when tissue that normally grows inside the uterus grows outside) and a higher risk of developing melanoma, a skin cancer. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 8, 2017 Category: Research Source Type: news

Waiting Even a Day to Remove Melanoma Can Be Deadly
No matter what stage their cancer was, those who waited more than 90 days for surgical treatment were more likely to die. (Source: WebMD Health)
Source: WebMD Health - November 7, 2017 Category: Consumer Health News Source Type: news

Waiting Even a Month to Remove Melanoma Can Be Deadly
Source: HealthDay Related MedlinePlus Pages: Melanoma (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 7, 2017 Category: Consumer Health News Source Type: news

Waiting Even a Month to Remove Melanoma Can Be Deadly
TUESDAY, Nov. 7, 2017 -- The sooner the deadly skin cancer melanoma is treated, the more likely a patient is to survive. Researchers analyzed data from more than 153,000 American adults diagnosed with stage 1 to 3 melanoma between 2004 and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 7, 2017 Category: General Medicine Source Type: news

Circulating tumor cells associated with relapse in late-stage melanoma patients
(University of Texas M. D. Anderson Cancer Center) A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as a potential predictor of patients at high risk for disease progression. CTCs, tumor cells shed into the bloodstream or lymphatic system, can lead to additional tumor growth and/or metastasis to distant sites. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news

Waiting Even a Month to Remove Melanoma Can Be Deadly
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news

First Tx for Erdheim-Chester Disease, a Rare Blood Cancer First Tx for Erdheim-Chester Disease, a Rare Blood Cancer
The first FDA-approved treatment for Erdheim-Chester dDisease (ECD), a rare blood cancer, is vemurafenib, a targeted therapy already used in melanoma with BRAF V600E mutations.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

What Causes White Nails?
Discussion The nail matrix covers the area of the nail plate, and extends proximally in a crescent moon shape with the edges of the crescent extending proximally and inferiorly toward the underlying bone. The nail matrix is a multilayered epithelium that physiologically produces keratinization and gives rise to the nail plate. The distal matrix forms the lower 2/3s of the nail plate and the proximal matrix forms the upper 1/3 of the nail plate. the thickness of the nail plate is proportion to the matrix’s thickness. The nail plate’s free edge contour follows the shape of the nail’s lunula. Melanocytes occ...
Source: PediatricEducation.org - November 6, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

7 medtech stories we missed this week: Nov. 3, 2017
[Image from unsplash.com]From Hologic’s new product launch to CapsoVision gettting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Hologic launches new MyoSure device Hologic announced in a Nov. 1 press release that it has launched its MyoSure Manual Device in the U.S. The device is designed to help doctors resect and remove intrauterine tissue easily in an office setting if used with the MyoSure hysteroscope. 2. IntraFuse wins FDA clearance for FlexThread fibula pin IntraFuse has received FDA 510(k) clearance for its FlexThread Fibula Pin System, ...
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Endoscopic / Arthroscopic Oncology Orthopedics Pain Management Regulatory/Compliance Surgical Ultrasound Women's Health brhmedical CapsoVision Helomics Hologic Inc. IntraFuse MedTech Sensus Healthcare LLC Skyline Med Source Type: news

Cancer treatment response may be affected by gut bacteria
Conclusion This early-stage study gives us some insights into factors that might influence people's responses to a specific type of cancer treatment (immunotherapy with monoclonal antibodies). The findings are of interest, but don't have any immediate implications for cancer treatment. We don't know what the conditions that required antibiotic treatment were and whether these could have affected the response to immunotherapy. We don't know whether the antibiotics themselves influenced how well the immunotherapy worked, or whether it was their effect on gut bacteria. We also don't know whether having high levels of part...
Source: NHS News Feed - November 3, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Having a curved penis brings a higher risk of cancer
A study of 1.5million men by Baylor College in Houston, Texas, found that a curved penis causes a higher risk of testicular cancer by 40%, melanoma by 29% and stomach cancer by 40%. (Source: the Mail online | Health)
Source: the Mail online | Health - November 2, 2017 Category: Consumer Health News Source Type: news

Bacteria in the gut modulates response to immunotherapy in melanoma
(University of Texas M. D. Anderson Cancer Center) Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2017 Category: Cancer & Oncology Source Type: news

Adjuvant BRAF and MEK Inhibition for Melanoma:'Impressive'Adjuvant BRAF and MEK Inhibition for Melanoma:'Impressive '
New at ESMO 2017, adjuvant dabrafenib/trametinib in stage III melanoma shows'impressive'results in relapse-free survival.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news